|View printer-friendly version|
During this time, investors will have the opportunity to discuss recent developments, including the launch of KindredBio's first product, key therapeutic programs in development, and upcoming milestones.
LD Micro San Francisco Summit
CL King 16th Annual
Webcast URL: Click here
An archived version of the above webcast will be available for 30 days on the Company's website.
Location: Parker New York
Important Safety Information
Mirataz® (mirtazapine transdermal ointment) is for topical use in cats only under veterinary supervision. Do not use in cats with a known hypersensitivity to mirtazapine or any of the excipients or in cats treated with monoamine oxidase inhibitors (MAOIs). Not for human use. Keep out of reach of children. Wear gloves to apply and wash hands after. Avoid contact with treated cat for 2 hours following application. The most common adverse reactions include application site reactions, behavioral abnormalities (vocalization and hyperactivity) and vomiting. Please see the full Prescribing Information.
About Kindred Biosciences
View original content with multimedia:http://www.prnewswire.com/news-releases/kindred-biosciences-to-participate-in-the-cl-king-16th-annual-best-ideas-conference-lake-street-capital-markets-2nd-annual-best-ideas-growth-conference-and-ld-micro-san-francisco-summit-300704636.html